Metixene
{{Short description|Chemical compound}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 394273486
| IUPAC_name = 1-methyl-3-(9H-thioxanthen-9-ylmethyl)piperidine
| image = Methixene.png
| image_class = skin-invert-image
| tradename =
| Drugs.com = {{drugs.com|international|metixene}}
| pregnancy_category =
| legal_AU =
| legal_BR = C1
| legal_BR_comment = {{Cite web |author=Anvisa |author-link=Brazilian Health Regulatory Agency |date=2023-03-31 |title=RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial |trans-title=Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control|url=https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992 |url-status=live |archive-url=https://web.archive.org/web/20230803143925/https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992 |archive-date=2023-08-03 |access-date=2023-08-16 |publisher=Diário Oficial da União |language=pt-BR |publication-date=2023-04-04}}
| legal_CA =
| legal_DE =
| legal_NZ =
| legal_UK =
| legal_US =
| legal_EU =
| legal_UN =
| legal_status =
| routes_of_administration =
| ATC_prefix = N04
| ATC_suffix = AA03
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| IUPHAR_ligand = 7232
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 4969-02-2
| PubChem = 4167
| DrugBank = DB00340
| ChemSpiderID = 4023
| UNII = 32VY6L26ZW
| KEGG = D08209
| ChEBI = 51024
| ChEMBL = 1201342
| C=20 | H=23 | N=1 | S=1
| SMILES = CN1CCCC(C1)CC2C3=CC=CC=C3SC4=CC=CC=C24
| StdInChI = 1S/C20H23NS/c1-21-12-6-7-15(14-21)13-18-16-8-2-4-10-19(16)22-20-11-5-3-9-17(18)20/h2-5,8-11,15,18H,6-7,12-14H2,1H3
| StdInChIKey = MJFJKKXQDNNUJF-UHFFFAOYSA-N
}}
Metixene (brand names Methixart, CholinFall, Tremonil, Trest), also known as methixene, is an anticholinergic used as an antiparkinsonian agent.{{cite book | chapter = Metixene | chapter-url = https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA178 | vauthors = Morton IK, Hall JM |title=Concise Dictionary of Pharmacological Agents: Properties and Synonyms |date=1999 |publisher=Springer Netherlands |location=Dordrecht |isbn=978-94-011-4439-1 |page=178}} It has also been reported to induce incomplete autophagy and cell death in metastatic cancer and brain metastases. {{cite journal |url=https://www.jci.org/articles/view/161142 |title=Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases |journal=Journal of Clinical Investigation |accessdate=3 November 2023 |doi=10.1172/JCI161142 |pmid=37847564 |year=2023|last1=Fares |first1=Jawad|doi-access=free |pmc=10721147 }}
See also
References
{{Reflist}}
{{Antiparkinson}}
{{Muscarinic acetylcholine receptor modulators}}
Category:Antiparkinsonian agents
Category:Muscarinic antagonists
{{nervous-system-drug-stub}}